Experimental drug leronlimab tested in 484 severe COVID-19 patients
NCT ID NCT04347239
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called leronlimab in 484 hospitalized adults with severe or critical COVID-19. Participants received weekly injections of the drug or a placebo to see if it could lower the risk of death and improve recovery. The trial is now complete, and results help understand whether this treatment can control severe disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONAVIRUS DISEASE 2019 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Cardiovascular, LLC
Alexander City, Alabama, 35010, United States
-
Atlantic Health System Hospital
Morristown, New Jersey, 07962-1905, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Baylor Scott & White Research Institute
Dallas, Texas, 75204, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Center for Advanced Research & Education (CARE)
Gainesville, Georgia, 30501, United States
-
Good Samaritan Hospital Corvallis
Corvallis, Oregon, 97330, United States
-
Holy Name Medical Center
Teaneck, New Jersey, 07666, United States
-
James A. Haley Veterans' Hospital
Tampa, Florida, 33612, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
New York Community Hospital of Brooklyn
Brooklyn, New York, 11229, United States
-
Novant Health
Winston-Salem, North Carolina, 27103, United States
-
Ohio Health
Columbus, Ohio, 43215, United States
-
Oregon Health and Sciences University
Portland, Oregon, 97239, United States
-
St. Barnabas
Livingston, New Jersey, 07052, United States
-
St. Jude Medical Center
Fullerton, California, 92835, United States
-
UCLA
Los Angeles, California, 90095, United States
-
University of Texas
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.